PI Name PI Organization Title Grant Number Initiative Program Director
Sowers, Lawrence C

University Of Texas Med Br Galveston
United States

Cytosine Deamination Adducts and Cancer Etiology 5R01CA228085-05
Balbo, Silvia

University Of Minnesota
United States

The DNA adductome of lung carcinogenesis 5R01CA220376-05 Wendy Wang, Ph.D., M.Sc.
Mantis, Nicholas J.

Wadsworth Center
United States

High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology 4U01CA260508-02 Lynn Sorbara, Ph.D.
Putluri, Nagireddy

Baylor College Of Medicine
United States

Identify the DNA Adduct and Associated Metabolic Alterations in Bladder Cancer of Smokers 5R01CA216426-05 Wendy Wang, Ph.D., M.Sc.
Sariol, Carlos A

University Of Puerto Rico Med Sciences
United States

SARS-CoV-2 correlates of protection in a Latino-origin population 3U01CA260541-02S1 Guillermo Marquez, Ph.D.
Kisiel, John

Mayo Clinic Rochester
United States

Multi-site Gastrointestinal Cancer Detection by Stool DNA Methylation 5R37CA214679-05 Matthew Young, Ph.D.
Zhang, Zhen

Johns Hopkins University
United States

Development of in vitro diagnostic multivariate index assay using liquid-based cervical cytology specimen and/or serum/plasma biomarkers for the detection of early stage or low-volume ovarian cancer 3U01CA200469-05S1 Christos Patriotis, Ph.D., M.Sc.
Houghton, A Mcgarry

Fred Hutchinson Cancer Center
United States

Tumor-specific autoantibodies for SCLC early detection 5R01CA243328-05 Lynn Sorbara, Ph.D.
Perelman, Lev T

Beth Israel Deaconess Medical Center
United States

Isolation and Assessment of Blood-Circulating Cancer Exosomes with LSS and SERS Lab on a Chip Optical Spectroscopic Instrument 5R01CA218382-05 PAR-16-276 (R01) Matthew Young, Ph.D.
Abbott, Karen L.

Florida International University
United States

Glycomics Laboratory for the Development of Ovarian Cancer Biomarkers 5U01CA226055-07 PAR-17-206 (U01) Christos Patriotis, Ph.D., M.Sc.